Evidence map›Paper›PMID 41158044›Full record

ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2025

[Research Progress on Local Treatment of Malignant Pleural Effusion].

Yanjun Du, Ping Zhan, Tangfeng Lv, Yong Song

Abstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yanjun DuDepartment of Respiratory and Critical Care Medicine, Jinling Clinical Medical College, Nanjing Medical University, Nanjing 210002, China.
Ping ZhanDepartment of Respiratory and Critical Care Medicine, Jinling Clinical Medical College, Nanjing Medical University, Nanjing 210002, China.
Tangfeng LvDepartment of Respiratory and Critical Care Medicine, Jinling Clinical Medical College, Nanjing Medical University, Nanjing 210002, China.
Yong SongDepartment of Respiratory and Critical Care Medicine, Jinling Clinical Medical College, Nanjing Medical University, Nanjing 210002, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant pleural effusion (MPE) refers to the accumulation of pleural fluid caused by metastasis from primary pleural malignancies or tumors originating elsewhere. It is associated with a poor prognosis. Current treatment strategies primarily include systemic anti-tumor therapy and local management of MPE based on the primary tumor. Numerous studies have documented diverse approaches for the local control of MPE. This review summarizes recent advances in local treatment strategies for primary tumor-related MPE, highlighting emerging pharmacological agents and innovative techniques.
.

Indexed as

Pleural Effusion, MalignantHumansImmune microenvironmentLocal therapiesMalignant pleural effusionProgress

Identifiers

PMID41158044
PMCPMC12580388

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.